相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gut microbial changes of patients with psychotic and affective disorders: A systematic review
Nina Vindegaard et al.
SCHIZOPHRENIA RESEARCH (2021)
Gut microbiome in Schizophrenia: Altered functional pathways related to immune modulation and atherosclerotic risk
Tanya T. Nguyen et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Profiling the differences of gut microbial structure between schizophrenia patients with and without violent behaviors based on 16S rRNA gene sequencing
Xiacan Chen et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2021)
Bile Acids: A Communication Channel in the Gut-Brain Axis
Vera F. Monteiro-Cardoso et al.
NEUROMOLECULAR MEDICINE (2021)
Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats
Chao Luo et al.
PSYCHOPHARMACOLOGY (2021)
The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial
Hamidreza Jamilian et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2021)
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Pascal Urwyler et al.
TRIALS (2021)
Lipid and Energy Metabolism of the Gut Microbiota Is Associated with the Response to Probiotic Bifidobacterium breve Strain for Anxiety and Depressive Symptoms in Schizophrenia
Ryodai Yamamura et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis
Ye Yang et al.
PSYCHOPHARMACOLOGY (2021)
The gut microbiome is associated with brain structure and function in schizophrenia
Shijia Li et al.
SCIENTIFIC REPORTS (2021)
Adiposity in schizophrenia: A systematic review and meta-analysis
Emily Smith et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkemansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice
Dongquan Huang et al.
PSYCHOPHARMACOLOGY (2021)
Gut microbial biomarkers for the treatment response in first-episode, drug-naive schizophrenia: a 24-week follow-up study
Xiuxia Yuan et al.
TRANSLATIONAL PSYCHIATRY (2021)
Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
Mirko Manchia et al.
BIOMEDICINES (2021)
Altered gut microbiota and mucosal immunity in patients with schizophrenia
Ruihuan Xu et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice
Feng Zhu et al.
MOLECULAR PSYCHIATRY (2020)
Analysis of gut mycobiota in first-episode, drug-naive Chinese patients with schizophrenia: A pilot study
Xue Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh et al.
NATURE COMMUNICATIONS (2020)
Alteration of the gut microbiome in first-episode drug-naive and chronic medicated schizophrenia correlate with regional brain volumes
Xiaoqian Ma et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Blazej Misiak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study
Rubing Pan et al.
PSYCHIATRY RESEARCH (2020)
Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics
Michal Lis et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Antipsychotics and glucose metabolism: how brain and body collide
Chantel Kowakhuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects
Tanya T. Nguyen et al.
SCHIZOPHRENIA RESEARCH (2019)
Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives
Raghunath Singh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study
Ryo Okubo et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent
Amy Chia-Ching Kao et al.
NEUROPHARMACOLOGY (2019)
Systematic Review of Gut Microbiota and Major Depression
Stephanie G. Cheung et al.
FRONTIERS IN PSYCHIATRY (2019)
Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension A Premise for Hypertension Therapy
Jasenka Zubcevic et al.
CIRCULATION RESEARCH (2019)
Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons
Chantel Kowalchuk et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons
Chantel Kowalchuk et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study
Justyna Pelka-Wysiecka et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia
Stephanie A. Flowers et al.
PHARMACOTHERAPY (2019)
Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
Karolina Skonieczna-Zydecka et al.
PSYCHOPHARMACOLOGY (2019)
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases
Emanuele Rinninella et al.
MICROORGANISMS (2019)
The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
S. Kanji et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Finding the needle in the haystack: systematic identification of psychobiotics
Aisling Bambury et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis
Ying He et al.
EUROPEAN PSYCHIATRY (2018)
Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder
Tanya T. Nguyen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex
Roshan R. Naik et al.
TRANSLATIONAL PSYCHIATRY (2018)
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Alex T. Raben et al.
FRONTIERS IN NEUROSCIENCE (2018)
The metabolic role of vagal afferent innervation
T. M. Zaved Waise et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia
Xiuxia Yuan et al.
SCHIZOPHRENIA RESEARCH (2018)
Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study
Yang Shen et al.
SCHIZOPHRENIA RESEARCH (2018)
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
Emanuel Schwarz et al.
SCHIZOPHRENIA RESEARCH (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Schizophrenia and the microbiome: Time to focus on the impact of antipsychotic treatment on the gut microbiota
Timothy G. Dinan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
The Brain-Gut-Microbiome Axis
Clair R. Martin et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Stephanie A. Flowers et al.
PHARMACOTHERAPY (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Introduction to the human gut microbiota
Elizabeth Thursby et al.
BIOCHEMICAL JOURNAL (2017)
Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study
Emily G. Severance et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Gut Microbiota: The Brain Peacekeeper
Chunlong Mu et al.
FRONTIERS IN MICROBIOLOGY (2016)
Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
Lieve Desbonnet et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
Jessica M. Yano et al.
CELL (2015)
Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
Pedro Goncalves et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders
John R. Kelly et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
Sarah M. Bahr et al.
EBIOMEDICINE (2015)
Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
Jakub Tomasik et al.
BIOMARKER INSIGHTS (2015)
Changes in Intestinal Glucocorticoid Sensitivity in Early Life Shape the Risk of Epithelial Barrier Defect in Maternal-Deprived Rats
Nabila Moussaoui et al.
PLOS ONE (2014)
The gut microbiota influences blood-brain barrier permeability in mice
Viorica Braniste et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Microbiota and neurodevelopmental windows: implications for brain disorders
Yuliya E. Borre et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Psychobiotics: A Novel Class of Psychotropic
Timothy G. Dinan et al.
BIOLOGICAL PSYCHIATRY (2013)
The gut microbiota - masters of host development and physiology
Felix Sommer et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries
Thomas Munk Laursen et al.
PLOS ONE (2013)
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
Emily G. Severance et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
K. J. Davey et al.
TRANSLATIONAL PSYCHIATRY (2013)
Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice
Yasunari Asano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Life expectancy and cardiovascular mortality in persons with schizophrenia
Thomas M. Laursen et al.
CURRENT OPINION IN PSYCHIATRY (2012)
γ-Aminobutyric acid production by culturable bacteria from the human intestine
E. Barrett et al.
JOURNAL OF APPLIED MICROBIOLOGY (2012)
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
Kieran J. Davey et al.
PSYCHOPHARMACOLOGY (2012)
A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
Vance L. Albaugh et al.
PLOS ONE (2011)
Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
Roberto Coccurello et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
William R. Wikoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
分享论文
